Mar. 14 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 27 November 2023Found: FOI 23/227 We are writing to you due to the update to the Valproate Pregnancy Prevention Program published
Feb. 20 2024
Source Page: Letters and medicine recalls sent to healthcare professionals in January 2024Found: Letters and medicine recalls sent to healthcare professionals in January 2024
Jan. 17 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 29 August 2022Found: Other factors could include a history of rash on other antiepileptic drugs, and age <13 years.
Correspondence Nov. 29 2023
Committee: Health and Social Care Committee (Department: Department of Health and Social Care)Found: Correspondence from Patient Safety Commissioner to the Chair on Sodium valproate 16.11.23 Correspondence
Nov. 28 2023
Source Page: MHRA instructs health organisations to prepare now for new measures to reduce ongoing serious harms of valproateFound: MHRA instructs health organisations to prepare now for new measures to reduce ongoing serious harms of valproate
Nov. 28 2023
Source Page: Valproate: review of safety data and expert advice on management of risksFound: Valproate: review of safety data and expert advice on management of risks
Mentions:
1: Henry Smith (Con - Crawley) a hereditary peer—in the other place. - Speech Link
2: Selaine Saxby (Con - North Devon) Anti-business rhetoric from Lib Dems is so damaging in a constituency such as mine. - Speech Link
3: Cat Smith (Lab - Lancaster and Fleetwood) Sodium valproate continues to be prescribed today, and for some women it will be the only medication - Speech Link
4: Laura Trott (Con - Sevenoaks) Member for Lancaster and Fleetwood is in her place, but I note her remarks on sodium valproate and will - Speech Link
Jul. 19 2023
Source Page: Human Medicines Regulations 2012 Advisory Bodies Annual Report 2022Found: SAFETY OF MARKETED MEDICINES Valproate – Use during pregnancy; impaired fertility in males 16
Jul. 19 2023
Source Page: Human Medicines Regulations 2012 Advisory Bodies Annual Report 2022Found: SAFETY OF MARKETED MEDICINES Valproate – Use during pregnancy; impaired fertility in males 16
Mentions:
1: None It has been a massive struggle—certainly for valproate, as well as for other areas—to get access to information - Speech Link
2: None One of the things that we are looking for, in Valproate Scotland, is implementation of the other Cumberlege - Speech Link
3: None pregnancy prevention plan and that they are on effective contraception.Since 2018, in England, we have - Speech Link
4: None guiding those of us in public bodies and others to new areas—in other words, the commissioner should - Speech Link